The labeling on many prescription drug products approved after 2001 will need to be reconfigured to include clearer information about whether a drug is safe to use during pregnancy, the US Food and ...
The US Food and Drug Administration (FDA) has finalized guidance to assist sponsors in evaluating drug safety during pregnancy after a drug has been approved. The purpose of these safety studies is to ...
The FDA on Friday issued guidance for manufacturers collecting postmarketing data on the safety of approved drugs and biologics in pregnancy, with the goal of better understanding potential risks for ...
US regulators are seeking to expand the knowledge base about potential side effects of medicines when taken during pregnancy because clinicians and their patients have long been concerned about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results